Ascend Laboratories, LLC is recalling 12,192 bottles of Rasagiline Mesylate 1 mg tablets because of a report of black spots and shiny metallic specks found on the tablets. Rasagiline Mesylate is a prescription medication used to treat Parkinson's disease. The recall affects 30-count HDPE bottles manufactured by Alkem Laboratories in India and distributed across 19 states and Puerto Rico. While one consumer complaint has been received, no injuries have been reported to date. If you have this medication, you should consult your pharmacist or doctor regarding replacement.
The presence of foreign metallic specks on oral tablets poses a potential risk of irritation or injury to the digestive tract if ingested. Although no injuries have been reported, the presence of an unknown metallic substance in medication is a serious quality and safety concern.
You have 2 options:
Distributed in 30 tablets in HDPE bottle; Rx only; Manufactured by Alkem Laboratories Ltd., India.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.